Role of lipid-derived mediators in skeletal muscle insulin resistance. - Wikidata - awgldk - TriplyDB

Role of lipid-derived mediators in skeletal muscle insulin resistance.

Role of lipid-derived mediators in skeletal muscle insulin resistance.

http://www.wikidata.org/entity/Q37551374

about

Mitochondrial fatty acid oxidation in obesity Lipocalin 13 regulation of glucose and lipid metabolism in obesity Insulin Signaling and Heart Failure.Adipokines: a treasure trove for the discovery of biomarkers for metabolic disorders.Lipocalin-13 regulates glucose metabolism by both insulin-dependent and insulin-independent mechanisms.Effects of Chronic Antagonism of Endocannabinoid-1 Receptors on Glucose Tolerance and Insulin Action in Skeletal Muscles of Lean and Obese Zucker Rats.Lipocalin 13 protein protects against hepatic steatosis by both inhibiting lipogenesis and stimulating fatty acid β-oxidation.Chronic renin inhibition with aliskiren improves glucose tolerance, insulin sensitivity, and skeletal muscle glucose transport activity in obese Zucker rats Bilobetin ameliorates insulin resistance by PKA-mediated phosphorylation of PPARα in rats fed a high-fat diet Excess of the endocannabinoid anandamide during lactation induces overweight, fat accumulation and insulin resistance in adult mice.Physically active vs. inactive lifestyle, muscle properties, and glucose homeostasis in middle-aged and older twins.Lipid peroxidation of poly-unsaturated fatty acids in normal and obese adipose tissues.Mitochondrial pathophysiology and type 2 diabetes mellitus.Defects in skeletal muscle subsarcolemmal mitochondria in a non-obese model of type 2 diabetes mellitus.Cannabinoid signalling inhibits sarcoplasmic Ca2+ release and regulates excitation-contraction coupling in mammalian skeletal muscle.Potential therapeutic role of resistance training in diabetes: a contribution by the 2009 recipient of the APS New Investigator Award.Adipose tissue function and dysfunction: organ cross talk and metabolic risk

P2860

Q26820838-17202C38-E26C-4280-A3CB-2DA98678BFA2 Q26996675-BB9949DF-C7C7-4B2A-A091-58C2DA6576B2 Q30377910-55769A34-F31D-4CC8-A675-8CBAC7B8E3EE Q34244082-5F855A86-44CA-4D82-87D5-C0983529B0D4 Q34528372-7355A6E2-0791-4AAC-9DD7-EDBD031C290B Q35005385-E189C5F8-9CC9-4BD7-819A-BBC63CE38E76 Q35515576-C391D328-368F-4516-8F00-79B8AEBB4508 Q35950287-AC8F5CF6-A985-449B-8A0C-5878B2D1BDB2 Q36176541-8E02556F-ADE3-4812-A4B3-F42D9F55F5FB Q36226578-F24049F7-AB3E-45B8-92B5-162DAAAA300E Q37179976-402CCAEA-07DA-464E-8F56-6A3F547C195C Q37851978-00C43389-4F6D-43AC-9B87-4070F53D4D0D Q37889277-10EDC785-BF59-4C65-ADE1-4FA1E31D8EC7 Q38603765-A2DDFC6E-4ED1-45E3-A9CE-6F5083242D55 Q48053644-1BAA3973-822C-422E-B890-EB551CCBB734 Q48304325-CB5448B1-2C79-4731-B7EF-74ED8A877516 Q58457084-2C6890A3-9810-4923-A4AA-A772E21D7108

P2860

Role of lipid-derived mediators in skeletal muscle insulin resistance.

http://www.wikidata.org/entity/Q37551374

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Role of lipid-derived mediators in skeletal muscle insulin resistance.

@en

Role of lipid-derived mediators in skeletal muscle insulin resistance.

@nl

type

label

Role of lipid-derived mediators in skeletal muscle insulin resistance.

@en

Role of lipid-derived mediators in skeletal muscle insulin resistance.

@nl

prefLabel

Role of lipid-derived mediators in skeletal muscle insulin resistance.

@en

Role of lipid-derived mediators in skeletal muscle insulin resistance.

@nl

P1433

Q37551374-0FAACC29-0B11-4667-AF0F-00686B984B99

P1476

Q37551374-A639ACCA-CE2B-4CE5-BF06-27595938C93F

P2093

Q37551374-51EBF4D3-0ECE-4D11-AC4F-D532193A1229

Q37551374-8897EF72-5C87-4B36-864B-58B332EE4DB8

P2860

Q37551374-00142E6A-27DA-4DC7-AEE2-1B0527DEDA8B

Q37551374-063D7490-4720-4F28-9D63-456B715ED0A7

Q37551374-06FC69F6-BEBF-4CC7-BB51-27B4F9DCE3AC

Q37551374-1297FF8C-A563-4BC0-8B9B-2571B4198051

Q37551374-1564FE78-0031-4616-A63B-2B9B6C69186F

Q37551374-1AA9746A-4D88-4FC3-A7EA-E6D42A039377

Q37551374-1FABA97A-D1DF-4BF5-B3F1-EEF338BD9500

Q37551374-29B8B77A-4C2F-4E82-B397-6EAD812663C9

Q37551374-2D8A6F86-383A-4F7B-A4C8-360BD1644173

Q37551374-2F039603-AAB7-486E-9032-5AB36EF786E5

P304

Q37551374-F8A927BD-0F49-4E31-9F6F-07D00B1B8784

P31

Q37551374-4354973D-C00F-49D8-A1BD-A09EF427B161

P356

Q37551374-9D05B12F-502F-4536-B9F0-CE3783BB46ED

P433

Q37551374-8C8AB8C9-65FF-4DF7-862D-E93AE730DB0E

P478

Q37551374-EF1357B5-6DC5-4F9D-93EF-A74D4A098270

P50

Q37551374-9FF28049-E8DC-4D45-B8C5-19AC59296966

P577

Q37551374-A87CBAB8-8DC1-4BAA-8359-52D72D4E9CD8

P5875

Q37551374-965670E2-6FDB-4942-B4FB-C65EC9C2399D

P698

Q37551374-8F7224BD-FE21-4EDC-BE16-E3903AB9FEC8

P921

Q37551374-04A94EF9-AAA1-45E1-8246-A5AEB65E7682

P356

AJPENDO.00241.2009

P1433

American Journal of Physiology - Endocrinology and Metabolism

P1476

Role of lipid-derived mediators in skeletal muscle insulin resistance

@en

P2093

Annika Taube

http://www.w3.org/2001/XMLSchema#string

Juergen Eckel

http://www.w3.org/2001/XMLSchema#string

P2860

Intramyocellular lipid kinetics and insulin resistance

Insulin signalling and the regulation of glucose and lipid metabolism

Malonyl CoenzymeA decarboxylase regulates lipid and glucose metabolism in human skeletal muscle

Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat

Mechanism of free fatty acid-induced insulin resistance in humans

Activation of the peripheral endocannabinoid system in human obesity

Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1

Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance

Leptin-regulated endocannabinoids are involved in maintaining food intake

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

P304

E1004-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPENDO.00241.2009

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

297

http://www.w3.org/2001/XMLSchema#string

P50

Kristin Eckardt

P577

2009-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26671187

http://www.w3.org/2001/XMLSchema#string

P698

19602581

http://www.w3.org/2001/XMLSchema#string

P921